ISASS is looking for leading-edge research and thought-provoking symposia formats–debates, discussions, case studies–for ISASS20, which will take place Feb. 26-28, 2020 at the Puerto Rico Convention Center in San Juan, Puerto Rico. Members and non-members may submit abstracts. The deadline is July 8. Click here to create and account and start the process.
At a meeting on May 2, at the Medical Device Manufacturers Association (MDMA) Annual Meeting, Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma publicly announced the agency’s comprehensive strategy to improve patients’ access to emerging technologies. Administrator Verma’s remark build on recently released CMS policies designed to promote innovation in the U.S. healthcare system. The Administration hopes that encouraging a competitive and innovative market will lead to lower overall healthcare costs for patient and the government and to increases in the quality of and access to healthcare for all Americans, including Medicare and Medicaid patients. Verma highlighted two specific actions in the address. First, CMS has recently announced changes to the process of updates and issuing Healthcare Common […]
Medicare announced on March 1, 2019, that 800 hospitals will be paid less by Medicare this year because of high rates of infections and patient injuries. The number is the highest since the federal government five years ago launched the Hospital Acquired Conditions (HAC) Reduction Program, created by the Affordable Care Act. This year, 110 hospitals are being punished for the fifth straight time. The penalties pit hospitals against one another in a race to prevent the most infections, blood clots, cases of sepsis, bedsores, hip fractures and other complications. Each year, the quarter of general hospitals with the highest rates are punished, even if their records have improved from the previous year. Under the announced sanctions, each hospital will lose 1 […]
The FDA Food and Drug Administration announced a sweeping plan on March 8, 2019, to review and address the safety of surgical staplers. In a letter sent to health-care providers Friday, the FDA said it will convene an advisory meeting on the safety of the devices and signaled that it might reclassify surgical staplers to put them under tighter control. The agency also said it plans to issue proposed recommendations to companies that make the devices, which are used in countless surgeries. The FDA also acknowledged in its letter that “we are aware that many more device malfunction reports during this time frame” were submitted as “summary reports,” which go to the FDA but are not included in the public database known […]